CHRS · Coherus Oncology, Inc.
$1.20
+0.06 (+5.26%)
At close · Aug 14
Market Cap
$185.40M
Shares
154.50M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-15 | 2026-06-12 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-06-01 | 2026-05-27 | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-20 | 2026-05-27 | |
| 8-K | 2026-03-09 | — | |
| 10-K | 2026-03-09 | 2025-12-31 | |
| 8-K | 2026-02-17 | 2026-02-12 | |
| 8-K | 2026-02-04 | — | |
| 8-K | 2026-01-23 | — | |
| 8-K | 2026-01-13 | — | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-08 | 2025-09-05 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-07-03 | 2025-06-30 | |
| 8-K | 2025-06-13 | 2025-06-11 | |
| 8-K | 2025-05-30 | 2025-05-29 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-11 | |
| 8-K | 2025-04-25 | 2025-04-22 | |
| 8-K | 2025-04-22 | 2025-04-16 | |
| 8-K | 2025-04-14 | 2025-04-11 | |
| 8-K | 2025-04-01 | 2025-03-31 | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-13 | 2025-03-11 | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-04 | 2024-11-27 | |
| 8-K | 2024-12-03 | 2024-12-02 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-09-13 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | 2024-08-07 | |
| 8-K | 2024-07-02 | 2024-06-27 | |
| 8-K | 2024-06-27 | 2024-06-26 | |
| 8-K | 2024-06-05 | 2024-05-31 | |
| 8-K | 2024-06-04 | 2024-05-29 | |
| 8-K/A | 2024-05-21 | 2024-05-08 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | 2024-05-08 | |
| 8-K | 2024-05-09 | — |
Showing 1–50 of 139 filings
Key facts
CIK
1512762
CUSIP
19249H103
13F (30d)
142 filings
138 filers
Visit website
Investor relations